Managing Renal Recovery from Amphotericin B Nephrotoxicity

Immediate Management Steps

The American College of Physicians and the Infectious Diseases Society of America recommend switching from conventional amphotericin B deoxycholate to lipid formulations, such as liposomal amphotericin B at 4-6 mg/kg daily, if continued antifungal therapy is required, as lipid formulations demonstrate significantly less nephrotoxicity while maintaining therapeutic efficacy 1, 2, 3, 4
The Centers for Disease Control and Prevention recommend aggressive electrolyte repletion, particularly potassium and magnesium, and maintenance of adequate hydration with normal saline, as hypokalemia occurs in up to 80% of patients and requires aggressive repletion to prevent further renal damage 1, 5
The National Institutes of Health recommend administering 0.9% normal saline 500-1000 mL IV over 30 minutes before any continued amphotericin B doses to maintain high urine output and facilitate tubular recovery 6, 5

The Clinical Infectious Diseases society recommends measuring serum creatinine and calculating creatinine clearance every 2-3 days initially, then weekly, and obtaining 24-hour urine collection for accurate creatinine clearance if using medications that interfere with creatinine secretion 1
The American College of Physicians recommends checking serum potassium, magnesium, calcium, and bicarbonate at least twice weekly, and monitoring for renal tubular acidosis by checking serum bicarbonate and arterial blood gas if acidosis is suspected 1, 5

The Infectious Diseases Society of America recommends providing oral potassium supplementation, even after drug discontinuation, and considering potassium-sparing diuretics if losses remain excessive 5, 1
The National Institutes of Health recommend monitoring hemoglobin weekly, as amphotericin B decreases renal erythropoietin production, and considering erythropoiesis-stimulating agents if hemoglobin falls below 10 g/dL and persists 6

The Centers for Disease Control and Prevention recommend avoiding or minimizing aminoglycosides, cyclosporine, tacrolimus, and NSAIDs during the recovery period, as concomitant nephrotoxic medications dramatically worsen outcomes and delay recovery 6, 1

The Clinical Infectious Diseases society recommends continuing monitoring renal function and electrolytes for at least 3-6 months after treatment completion, as permanent tubular dysfunction may require ongoing potassium and magnesium supplementation 7, 5

The American College of Physicians recommends dose adjustment for patients with pre-existing renal impairment, extending the dosing interval to every 24-36 hours when creatinine clearance is <10 mL/min, and preferring lipid formulations in this population 1
The National Institutes of Health recommend monitoring for volume overload in hemodialysis patients, given the inability to excrete sodium load, and continuing standard dosing on the patient's usual schedule 1